Vimta Labs Ltd | Industry : (Healthcare) | |
---|---|---|
BSE Code : 524394 |
NSE Symbol : VIMTALABS |
P/E(TTM) : 32.49 |
ISIN Demat : INE579C01029 |
Div & Yield% : 0.35 |
EPS(TTM) : 17.51 |
Book Value(₹) : 142.66 |
Market Cap(₹Cr) : 1,261.28 |
Face Value(₹) : 2.00 |
Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Gross Sales | 80.20 | 78.34 | 80.10 | 72.26 | 82.19 | 80.80 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 80.20 | 78.34 | 80.10 | 72.26 | 82.19 | 80.80 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 0.69 | 0.49 | 0.89 | 2.04 | 0.59 | 0.67 |
Total Income | 80.89 | 78.83 | 80.99 | 74.30 | 82.79 | 81.47 |
Total Expenditure | 56.60 | 54.71 | 59.22 | 56.97 | 58.36 | 57.24 |
PBIDT | 24.29 | 24.11 | 21.77 | 17.34 | 24.43 | 24.22 |
Interest | 0.48 | 0.53 | 0.53 | 0.62 | 0.44 | 0.25 |
PBDT | 23.81 | 23.58 | 21.24 | 16.72 | 23.99 | 23.98 |
Depreciation | 8.15 | 8.03 | 8.64 | 8.87 | 8.45 | 8.00 |
Tax | 3.97 | 4.68 | 3.56 | 3.40 | 4.50 | 3.75 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 0.06 | -0.93 | -0.42 | -1.47 | -0.59 | -0.02 |
Reported Profit After Tax | 11.64 | 11.80 | 9.46 | 5.92 | 11.63 | 12.25 |
Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Profit After Extra-ordinary item | 11.64 | 11.80 | 9.46 | 5.92 | 11.63 | 12.25 |
EPS (Unit Curr.) | 5.25 | 5.34 | 4.26 | 2.67 | 5.25 | 5.54 |
EPS (Adj) (Unit Curr.) | 5.25 | 5.34 | 4.26 | 2.67 | 5.25 | 5.54 |
Calculated EPS (Unit Curr.) | 5.25 | 5.32 | 4.27 | 2.67 | 5.25 | 5.54 |
Calculated EPS (Adj) (Unit Curr.) | 5.25 | 5.32 | 4.27 | 2.67 | 5.25 | 5.54 |
Calculated EPS (Ann.) (Unit Curr.) | 21.00 | 21.29 | 17.06 | 10.70 | 21.01 | 22.14 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | 21.00 | 21.29 | 17.06 | 10.70 | 21.01 | 22.14 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity | 4.43 | 4.43 | 4.43 | 4.43 | 4.43 | 4.43 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | 30.29 | 30.78 | 27.18 | 24.00 | 29.72 | 29.98 |
PBDTM(%) | 29.69 | 30.10 | 26.52 | 23.14 | 29.19 | 29.68 |
PATM(%) | 14.51 | 15.06 | 11.81 | 8.19 | 14.15 | 15.16 |